Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bergogne

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
European Urology|January 1, 1987
Bacterial host interaction in the pathogenesis and management of lower urinary tract infectionE Bergogne-Bérézin
La Revue De Medecine Interne|November 1, 1986
[Biological bases for the use of ceftazidime in anti-infection therapy]E Bergogne-Berezin
Presse Medicale (Paris, France : 1983)|January 8, 1999
[New development in clinical pharmacology of anti-infective agents]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|April 12, 1997
[Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts]E Bergogne-Bérézin
La Revue Du Praticien|October 22, 1998
[The birth of hospital bacteriology]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|December 14, 1996
[New pharmacologic approaches to macrolides: example of roxithromycin]E Bergogne-Bérézin
Drugs|August 10, 1999
Current guidelines for the treatment and prevention of nosocomial infectionsE Bergogne-Bérézin
La Revue Du Praticien|January 5, 2002
[Antibacterial antibiotics. Classification, principles and utilization rules]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|January 13, 2001
[West Nile virus (WNV) encephalitis]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|December 25, 2002
[Anti-infective agents and bacterial resistance, monitor, eradicate or avoid resistance?]E Bergogne-Bérézin
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
European Urology|January 1, 1987
Bacterial host interaction in the pathogenesis and management of lower urinary tract infectionE Bergogne-Bérézin
La Revue De Medecine Interne|November 1, 1986
[Biological bases for the use of ceftazidime in anti-infection therapy]E Bergogne-Berezin
Presse Medicale (Paris, France : 1983)|January 8, 1999
[New development in clinical pharmacology of anti-infective agents]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|April 12, 1997
[Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts]E Bergogne-Bérézin
La Revue Du Praticien|October 22, 1998
[The birth of hospital bacteriology]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|December 14, 1996
[New pharmacologic approaches to macrolides: example of roxithromycin]E Bergogne-Bérézin
Drugs|August 10, 1999
Current guidelines for the treatment and prevention of nosocomial infectionsE Bergogne-Bérézin
La Revue Du Praticien|January 5, 2002
[Antibacterial antibiotics. Classification, principles and utilization rules]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|January 13, 2001
[West Nile virus (WNV) encephalitis]E Bergogne-Bérézin
Presse Medicale (Paris, France : 1983)|December 25, 2002
[Anti-infective agents and bacterial resistance, monitor, eradicate or avoid resistance?]E Bergogne-Bérézin
Pageof 21